Medical Procedure News

RSS

Gamma Knife stereotactic radiosurgery safe for treating children with arteriovenous malformations: Study

A new Mayo Clinic study has found that Gamma Knife™ stereotactic radiosurgery is a safe and effective option for selected children with arteriovenous malformations. This study was presented at the American Association of Neurological Surgeons Annual Meeting in Philadelphia last week.

12 May 2010

Periodontal disease treatment reduces blood sugar levels in Type 2 diabetes patients

A study to be published in the latest issue of The Cochrane Library and led by researchers at the University of Edinburgh and supported by colleagues at the Peninsula Dental School, the University of Ottawa and UCL Eastman Dental Institute, suggests that the treatment of serious gum (periodontal) disease in diabetics with Type 2 diabetes may lower their blood sugar levels.

12 May 2010

Stereotaxis launches Vdrive module for remote manipulation of diagnostic devices during EP procedures

Stereotaxis, Inc. today announces the introduction of its new Vdrive™, an expansion of its Magnetic Navigation platform that facilitates remote manipulation of diagnostic devices used during electrophysiology (EP) procedures. The company is planning to preview the Vdrive at the HRS meeting this week, and will be commercially available when regulatory processes are complete.

12 May 2010

Solta Medical, Alma Lasers resolve Thermage patent lawsuits

Solta Medical, Inc., Alma Lasers Ltd. and Alma Lasers, Inc. today announced that they have reached an agreement resolving lawsuits involving certain Thermage® patents held by Solta Medical.

12 May 2010

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) of its AnalyST™ implantable cardioverter defibrillator (ICD) with ST Monitoring, a revolutionary device that not only provides life-saving therapy for dangerously fast heart rhythms, but also continuously monitors electrical changes (called ST segments) to help physicians monitor for cardiac problems.

12 May 2010

FDA approves delivery of Cefepime in B. Braun's DUPLEX System

The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug Delivery System.

From B. Braun Melsungen AG 12 May 2010

Phakic IOLs safer than laser surgery for correcting moderate short-sightedness

A new type of procedure for correcting short-sightedness could be safer than laser eye surgery, according to a new Cochrane Systematic Review. The study also shows that patients prefer the new procedure, despite there being little difference between the two in terms of improving vision.

12 May 2010

Quest initiates dosing in Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.

12 May 2010

Viking Systems to demonstrate 3DHD Vision System prototype at Hospital Build Asia 2010

Viking Systems, Inc. today announced that a prototype version of its Next Generation 3DHD Vision System will be demonstrated with Sony's prototype 3DHD Medical Display in Sony's booth at Hospital Build Asia 2010 which will run May 11 -13 in Singapore.

11 May 2010

Isolite Systems to launch LED Smart Stick for dryfield illuminator at "The Art & Science of Dentistry" meeting

Isolite Systems, maker of innovative dental isolation technology, will debut an even brighter, more technically advanced LED Smart Stick for its award-winning Isolite dryfield illuminator during the California Dental Association's "The Art & Science of Dentistry" scientific meeting and exhibition held May 13 -16, 2010 at the Anaheim Convention Center.

11 May 2010

Hothead Technologies, Shafer partner to develop normothermia monitoring and management system

Hothead Technologies has executed an agreement with Shafer Medical Devices, a Division of Shafer Enterprises, LLC to develop and distribute a medical application of the H.O.T.™ System that supports the Shafer Medical Devices Hypo/Hyperthermic Pad in managing normothermia in patients, during pre-op, surgery, and post op.

11 May 2010

Limiting fat intake to below 20% can reduce risk of breast cancer recurrence by 24%

When one of the country's foremost physicians—people like Dr. Andrew Weil—need someone to care for their friends and family dealing with cancer, the man they turn to is Keith Block, M.D. "I believe in Keith's program and would head to the Block Center if I were facing a diagnosis of cancer. It is where I have and will continue to send my friends and family," said Dr. Weil.

11 May 2010

Potential new drug therapies for treatment of tuberculosis

Tuberculosis (TB) has been present in humans since ancient times. The origins of the disease date back to the first domestication of cattle, and skeletal remains show prehistoric humans (4,000 B.C.) had TB. Although relatively rare in the United States, it is the single leading bacterial cause of death worldwide. Approximately 8 million people are infected each year and 2 million people die from TB.

11 May 2010

Cancer costs double in 20 years but are still in line with overall health spending, study finds

USA Today: "The cost of treating cancer has doubled over the past 20 years, but those costs are in line with overall trends in health spending. And while more people are getting cancer as the U.S. population ages, treatment has shifted away from hospitals to outpatient settings, finds a study in Monday's edition of the journal Cancer.

11 May 2010

New multicenter trial achieves 71% survival in AML children

More individualized therapy and better supportive care helped push the survival for children with acute myeloid leukemia (AML) to 71 percent three years after diagnosis, according to new research led by St. Jude Children's Research Hospital investigators and reported in the medical journal The Lancet Oncology. The survival rate of 71 percent is 20 percent better than previously reported U.S. rates and is similar to the success achieved in a 2009 Japanese study, said Jeffrey Rubnitz, M.D., Ph.D., a member of the St. Jude Oncology department.

11 May 2010

New law could help hospice patients continue aggressive medical treatments

Kaiser Health News staff writer Jordan Rau, in collaboration with The Philadelphia Inquirer, reports: "After an excruciating bout of chemotherapy, Linda Meisenhelder gave up fighting colon cancer and last fall entered end-of-life hospice care.

11 May 2010

BIOTRONIK launches TactiCath irrigated RF contact force ablation catheter for treating AF

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of remote monitoring technologies today announced the market release of the TactiCath catheter. The TactiCath catheter, an Endosense company product, is an irrigated RF contact force ablation catheter with features that offer a major advance in ablation therapy for patients with cardiac arrhythmias and particularly Atrial Fibrillation (AF).

11 May 2010

Aesculap Implant Systems introduces S4 Element Pedicle Screw System

Aesculap Implant Systems, LLC is pleased to announce the launch of the S4® Element™ Pedicle Screw System.

11 May 2010

Multicomponent psychological intervention helps reduce alexithymia and cancer pain

An Italian study published in the current issue of Psychotherapy and Psychosomatics examines the relationship between cancer pain and inability to express feelings and the effects of treatment.

10 May 2010

Study results of CTT's Calmare Pain Therapy for CIPN to be presented

Competitive Technologies, Inc. announced today that Thomas J. Smith, M.D., Endowed Chair of Palliative Care Research and Medical Director of the Thomas Palliative Care Unit Virginia Commonwealth University's Massey Cancer Center, will present results of his study evaluating the treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTT's Calmare® Pain Therapy Treatment.

10 May 2010

Medical Procedure News

Gamma Knife stereotactic radiosurgery safe for treating children with arteriovenous malformations: Study

Periodontal disease treatment reduces blood sugar levels in Type 2 diabetes patients

Stereotaxis launches Vdrive module for remote manipulation of diagnostic devices during EP procedures

Solta Medical, Alma Lasers resolve Thermage patent lawsuits

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

FDA approves delivery of Cefepime in B. Braun's DUPLEX System

Phakic IOLs safer than laser surgery for correcting moderate short-sightedness

Quest initiates dosing in Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients

Viking Systems to demonstrate 3DHD Vision System prototype at Hospital Build Asia 2010

Isolite Systems to launch LED Smart Stick for dryfield illuminator at "The Art & Science of Dentistry" meeting

Hothead Technologies, Shafer partner to develop normothermia monitoring and management system

Limiting fat intake to below 20% can reduce risk of breast cancer recurrence by 24%

Potential new drug therapies for treatment of tuberculosis

Cancer costs double in 20 years but are still in line with overall health spending, study finds

New multicenter trial achieves 71% survival in AML children

New law could help hospice patients continue aggressive medical treatments

BIOTRONIK launches TactiCath irrigated RF contact force ablation catheter for treating AF

Aesculap Implant Systems introduces S4 Element Pedicle Screw System

Multicomponent psychological intervention helps reduce alexithymia and cancer pain

Study results of CTT's Calmare Pain Therapy for CIPN to be presented

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News